Archives of Clinical Infectious Diseases

Published by: Kowsar

Coverage and Long-Term Immunogenicity of Hepatitis B Vaccine in Healthcare Workers

Omid Aminian 1 , Maryam Moaven Saidi 1 , Khosro Sadeghniiat Haghighi 2 and Nazanin Izadi 1 , *
Authors Information
1 Center for Research on Occupational Diseases, Tehran University of Medical Sciences, Tehran, IR Iran
2 Occupational Sleep Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: October 01, 2016, 11 (4); e35758
  • Published Online: July 26, 2016
  • Article Type: Research Article
  • Received: December 26, 2015
  • Revised: July 27, 2016
  • Accepted: July 5, 2016
  • DOI: 10.5812/archcid.35758

To Cite: Aminian O, Moaven Saidi M, Sadeghniiat Haghighi K, Izadi N. Coverage and Long-Term Immunogenicity of Hepatitis B Vaccine in Healthcare Workers, Arch Clin Infect Dis. 2016 ; 11(4):e35758. doi: 10.5812/archcid.35758.

Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Sepkowitz KA, Eisenberg L. Occupational deaths among healthcare workers. Emerg Infect Dis. 2005; 11(7): 1003-8[DOI][PubMed]
  • 2. Beltrami EM, Williams IT, Shapiro CN, Chamberland ME. Risk and management of blood-borne infections in health care workers. Clin Microbiol Rev. 2000; 13(3): 385-407[PubMed]
  • 3. Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: a review article. J Res Med Sci. 2009; 14(4): 249-58[PubMed]
  • 4. Talaat M, Kandeel A, El-Shoubary W, Bodenschatz C, Khairy I, Oun S, et al. Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt. Am J Infect Control. 2003; 31(8): 469-74[DOI][PubMed]
  • 5. Baba M. Evaluation of hepatitis b antibody (hbs) levels in nursing staff of gaemshahr razi hospital and it. 2000;
  • 6. Shefer A, Atkinson W, Friedman C, Kuhar DT, Mootrey G, Bialek SR. Cartographers. Immunization of health-care personnel: Recommendations of the advisory committee on immunization practices (acip),recommendations and reports
  • 7. Poorolajal J, Mahmoodi M, Haghdoost A, Majdzadeh R, Nasseri-Moghaddam S, Ghalichi L, et al. Booster dose vaccination for preventing hepatitis B. Cochrane Database Syst Rev. 2010; (11)[DOI][PubMed]
  • 8. National accreditation of hospitals in Iran. 2011;
  • 9. Schillie S, Murphy TV, Sawyer M, Ly K, Hughes E, Jiles R, et al. CDC guidance for evaluating health-care personnel for hepatitis B virus protection and for administering postexposure management. MMWR Recomm Rep. 2013; 62: 1-19[PubMed]
  • 10. Werner BG, Grady GF. Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity. Ann Intern Med. 1982; 97(3): 367-9[PubMed]
  • 11. Bond WW, Favero MS, Petersen NJ, Gravelle CR, Ebert JW, Maynard JE. Survival of hepatitis B virus after drying and storage for one week. Lancet. 1981; 1(8219): 550-1[PubMed]
  • 12. Dienstag JL, Werner BG, Polk BF, Snydman DR, Craven DE, Platt R, et al. Hepatitis B vaccine in health care personnel: safety, immunogenicity, and indicators of efficacy. Ann Intern Med. 1984; 101(1): 34-40[PubMed]
  • 13. Zajac BA, West DJ, McAleer WJ, Scolnick EM. Overview of clinical studies with hepatitis B vaccine made by recombinant DNA. J Infect. 1986; 13 Suppl A: 39-45[PubMed]
  • 14. Francis DP, Hadler SC, Thompson SE, Maynard JE, Ostrow DG, Altman N, et al. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men. Ann Intern Med. 1982; 97(3): 362-6[PubMed]
  • 15. Immunization and infectious diseases-healthy people. Healthy People. 2010;
  • 16. Byrd KK, Lu PJ, Murphy TV. Hepatitis B vaccination coverage among health-care personnel in the United States. Public Health Rep. 2013; 128(6): 498-509[PubMed]
  • 17. De Schryver A, Claesen B, Meheus A, van Sprundel M, Francois G. European survey of hepatitis B vaccination policies for healthcare workers. Eur J Public Health. 2011; 21(3): 338-43[DOI][PubMed]
  • 18. Gyawali P, Rice PS, Tilzey AJ. Exposure to blood borne viruses and the hepatitis B vaccination status among healthcare workers in inner London. Occup Environ Med. 1998; 55(8): 570-2[PubMed]
  • 19. Manso VF, Castro KF, Matos SM, Junqueira AL, Souza SB, Sousa MM, et al. Compliance with hepatitis B virus vaccination and risk of occupational exposure to blood and other body fluids in intensive care department personnel in Brazil. Am J Infect Control. 2003; 31(7): 431-4[DOI][PubMed]
  • 20. Chathuranga LS, Noordeen F, Abeykoon AM. Immune response to hepatitis B vaccine in a group of health care workers in Sri Lanka. Int J Infect Dis. 2013; 17(11)-9[DOI][PubMed]
  • 21. Grosso G, Mistretta A, Marventano S, Ferranti R, Mauro L, Cunsolo R, et al. Long-term persistence of seroprotection by hepatitis B vaccination in healthcare workers of southern Italy. Hepat Mon. 2012; 12(9)[DOI][PubMed]
  • 22. Ganczak M. A cross-sectional study on anti hepatitis B immune status in vaccinated healthcare workers in the west pomeranian region of poland. Hepat Mon. 2012; 12(3): 185-9[DOI][PubMed]
  • 23. Russi MB, Howarth MV. Occupational medicine in healthcare industry. 2005;
  • 24. Lu CY, Ni YH, Chiang BL, Chen PJ, Chang MH, Chang LY, et al. Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis. 2008; 197(10): 1419-26[DOI][PubMed]
  • 25. Floreani A, Baldo V, Cristofoletti M, Renzulli G, Valeri A, Zanetti C, et al. Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers. Vaccine. 2004; 22(5-6): 607-10[PubMed]
  • 26. Ikeda Y, Noda J, Inoue Y, Isogai N. Efficacy of hepatitis B surface antigen vaccination of Japanese healthcare workers and the importance of immunosurveillance. European J Health. 2013; 2013
  • 27. Durrani T, Harrison R, Joseph L. Occupational infections Current Occupational and Environmental Medicine. 2014;
  • 28. Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011; 53(1): 68-75[DOI][PubMed]
  • 29. Zamani F, Fallahian F, Hashemi F, Shamsaei Z, Alavian SM. Immune response to hepatitis B vaccine in health-care workers. Saudi J Kidney Dis Transpl. 2011; 22(1): 179-84[PubMed]
  • 30. Nakao K, Hamasaki K, Wakihama N, Maeda M, Ohtsubo N, Sagiike T, et al. Analysis of anti-HBs levels in healthcare workers over 10 years following booster vaccination for hepatitis B virus. Vaccine. 2003; 21(25-26): 3789-94[PubMed]
  • 31. Alavian SM, Rajai M, Arab M, Gashtasebifar S, Emadi V, Nejatbakhsh P, et al. Viral hepatitis in iranian armed forces: prevalence of HBV and HCV in the wounded-in-action (WIA). Hepatmon. 2005; 5(4): 129-31
  • 32. Mohsenzade M, Pirouzi A, Jafari M, Azadi M, Raeiszadeh-Jahromi S, Afkari R. Study on the serum titer of anti-hbs antibody of the vaccinated staffs of a hospital in three consecutive years. ZJRMS. 2013; 15(12): 23-7
  • 33. Shaw FJ, Guess HA, Roets JM, Mohr FE, Coleman PJ, Mandel EJ, et al. Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccination. Vaccine. 1989; 7(5): 425-30[PubMed]
  • 34. Dannetun E, Tegnell A, Torner A, Giesecke J. Coverage of hepatitis B vaccination in Swedish healthcare workers. J Hosp Infect. 2006; 63(2): 201-4[DOI][PubMed]
  • 35. McMahon BJ, Dentinger CM, Bruden D, Zanis C, Peters H, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 22-year follow-up study and response to a booster dose. J Infect Dis. 2009; 200(9): 1390-6[DOI][PubMed]
  • 36. Durlach R, Laugas S, Freuler CB, Rodriguez VE, Costa M. Ten-year persistence of antibody to hepatitis B surface antigen in healthcare workers vaccinated against hepatitis B virus, and response to booster vaccination. Infect Control Hosp Epidemiol. 2003; 24(10): 773-6[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments